News

BioM's articles and press releases about the Bavarian biotechnology sector


Apply for the 8th batch of the 4C Accelerator by July 19!

You have an in­nov­at­ive product idea in the MedTech sec­tor? You want to de­vel­op a prom­ising busi­ness model and learn how to…

BioM publishes report „Biotech in Bavaria 2023/24“: Bavarian biotechnology grows and achieves record financing

Auf der dies­jährigen BayOCon­nect-Kon­fer­enz präsen­tierte BioM den ak­tuel­len Jahresre­port "Bi­otech in Bav­aria 2023/24 –…

MAxL in Martinsried: Bio M opens new start-up incubator - 8.5 million euros for innovative start-up teams to strengthen biotechnology in Bavaria

BioM Bi­otech Cluster Devel­op­ment GmbH to­geth­er with State Sec­ret­ary To­bi­as Got­thardt has of­fi­cially opened the start-up…

BioFIT 2024 - get the BioM discount

We offer our net­work 20% dis­count for BioFIT 2024 - Decem­ber 3rd and 4th, 2024 | In-per­son, Lille (France) and Decem­ber 11th & 12th,…

BARDA VITAL Prize (BVP) Challenge: BARDA VITAL Global Health Security Symposium in Berlin

VITAL is on the hunt for break­through vac­cines and thera­peut­ics plat­forms and en­abling tech­no­lo­gies, and it is call­ing on bi­otech…

Eisbach Bio announces FDA clearance of IND application for EIS-12656, a first-in-class allosteric inhibitor of ALC1

Eis­bach Bio GmbH, a privately-held clin­ic­al-stage bi­o­tech­no­logy com­pany in Martin­sried pi­on­eer­ing can­cer medi­cines lever­aging…

PELOBIOTECH GmbH announces collaboration with HVD Life Science Vertriebs GmbH to bring revolutionary Poietis’ Next-Gen Bioprinter to Germany

Bi­o­tech­no­logy com­pany Pelo­bi­otech GmbH from Planegg/Martin­sried, an­nounces a stra­tegic part­ner­ship with HVD Life Science…

m4 Award winner Tubulis on the road to success: 128 million euros in Series B2 funding for the fight against solid tumors

The Mu­nich Bi­otech-Star­tup and m4 Award win­ner Tubulis, loc­ated in Planegg/Martin­sried closes an up­sized EUR 128 mil­lion Ser­ies B2…

ITOC in Munich: 10th Immunotherapy of Cancer Conference

The Im­mun­o­ther­apy of Can­cer Con­fer­ence (ITOC) is a European meet­ing provid­ing a glob­al plat­form for trans­la­tion­al re­search in…

Newsletter

Subscribe

Archive


30.07.2024

Friedrich-Alexander-Universität Erlangen-Nürnberg

Wie Com­puter durch Laser blitz­schnell wer­den und KI die En­er­giewende bee­in­flusst

30.07.2024

Verband angestellter Akademiker und leitender Angestellter der chemischen Industrie e. V. (VAA – Führungskräfte Chemie)

Stim­mung in Chemie und Pharma weit­er­hin gedäm­pft

30.07.2024

Helmholtz-Zentrum für Infektionsforschung (HZI),Helmholtz Institute for RNA-based Infection Research (HIRI)

Den Datend­schun­gel durch­schauen

29.07.2024

LIT - Leibniz-Institut für Immuntherapie

„S­prin­gende Gene“ un­ter­stützen Im­mun­zel­len im Gewebe

29.07.2024

Julius-Maximilians-Universität Würzburg

Wenig Ver­trauen in Dr. ChatGPT


Publish press release

 To the login


Gabriele Klingner
Gabriele Klingner

Communications & Marketing Lead


Christiane Proll
Christiane Proll

PR & Social Media Manager